JADO's mission is to become the leader in the emerging field of RAFT intervention therapeutics, through the development of novel pharmaceutical products with potential for treating a wide range of human diseases.
RAFTs are sub-compartments of cell membranes that play an integral role in key biological pathways. Using its revolutionary drug development platform called, RAFT Intervention Technology®, JADO is exploiting new insights and understanding of cell membrane chemistry and organization that enables us to address difficult to treat diseases, such as allergies (atopic dermatitis, asthma), viral and bacterial infections, cancer, neurodegenerative diseases (Alzheimer's) and metabolic illnesses (diabetes, lipid storage diseases). |
